All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention CORI Surgical System, the most common co-covered peer. Smith & Nephew appears in 1 tracked Healthcare story from March 2, 2026. The tracked stories average 2 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Smith & Nephew
All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention CORI Surgical System, the most common co-covered peer. Smith & Nephew appears in 1 tracked Healthcare story from March 2, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Smith & Nephew. Shared-story counts are live from our verified record — not editorial picks.
Smith & Nephew has introduced ambitious financial targets for FY26 and FY28, signaling a definitive shift from its operational recovery phase to a sustained growth trajectory. The company’s Q4 results underscore the resilience of its Orthopaedics and Sports Medicine segments, supported by the continued rollout of the CORI robotics platform.